SABRE (Southeast Asia Benefit-Risk Evaluation)

1. Description

SABRE is another recent initiative in Southeast Asia to promote better assessment of benefits and risks of medicine, but has not yet released any details to date.[1] SABRE is subsumed under the UMBRA Initiative.

2. Evaluation

  • There is currently no published details on SABRE.

3. References

[1] CIRS Workshop Synopsis on Benefit-Risk. Building the benefit-risk toolbox: Are there enough common elements across the different methodologies to enable a consensus on a scientifically acceptable framework for making benefit-risk decisions? 20-6-2012. Washington, DC, Centre for Innovation in Regulatory Science.